Brief: Wuxi Biologics Notes Letter From Certain United States Of America Lawmakers
Feb 14 (Reuters) - WuXi Biologics (Cayman) Inc
2269.HK :
* CLARIFICATION ANNOUNCEMENT
* NOTED LETTER FROM CERTAIN UNITED STATES OF AMERICA
LAWMAKERS
* WOULD LIKE TO CLARIFY THAT COMPANY IS NOT A SUBSIDIARY OF
WUXI
APPTEC CO
* LIKE TO REITERATE THAT IT HAS NOT, DOES NOT AND WILL NOT
POSE
ANY NATIONAL SECURITY RISK TO U.S. OR ANY OTHER COUNTRY
Source text for Eikon: ID:n11068595-1
Further company coverage: 2269.HK
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln